Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tendon rupture associated with simvastatin/ezetimibe therapy.

Raja C Pullatt1, Mamatha Reddy Gadarla, Richard H Karas

  • 1Department of Internal Medicine, University of Connecticut, Farmington, Connecticut, USA.

The American Journal of Cardiology
|June 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A values-driven academic affiliation between a public medical school and a private healthcare provider: exploring the perceptions of key opinion leaders.

Frontiers in health services·2025
Same author

Impact of Statin Therapy on Mortality and Rehospitalization in Acute Heart Failure Patients Stratified by Ejection Fraction: Insights from the Gulf CARE Registry.

Current vascular pharmacology·2025
Same author

Morbidity and mortality of acute heart failure patients stratified by mitral regurgitation in the Arabian Gulf: Observations from the Gulf acute heart failure registry (Gulf CARE).

Heliyon·2023
Same author

Social Determinants of Health and Mortality After Premature and Non-premature Acute Coronary Syndrome.

Mayo Clinic proceedings. Innovations, quality & outcomes·2023
Same author

The "obesity paradox" in patients with atrial fibrillation: Insights from the Gulf SAFE registry.

Frontiers in cardiovascular medicine·2022
Same author

Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry).

The American journal of cardiology·2022

Simvastatin and ezetimibe (Vytorin) may increase the risk of tendon rupture. These cholesterol drugs might alter matrix metalloproteinase activity, hindering tendon repair and increasing injury likelihood.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Orthopedic Surgery

Background:

  • Tendon rupture is often associated with pre-existing tendon injuries.
  • Physiological tendon repair involves extracellular matrix remodeling mediated by matrix metalloproteinases (MMPs).

Observation:

  • A physician experienced spontaneous biceps tendon rupture while taking simvastatin and ezetimibe.
  • Re-administration of the medication led to tendinopathy in the opposite biceps tendon, which resolved upon discontinuation.

Findings:

  • Statins are known to inhibit MMPs.
  • This inhibition may disrupt the natural degradation and remodeling processes essential for tendon healing.
  • Altered MMP activity due to statin use is hypothesized to increase the risk of tendon rupture.

Related Experiment Videos

Implications:

  • Clinicians should consider the potential risk of tendon rupture in patients using statins, particularly those with a history of tendon injury.
  • Further research is warranted to elucidate the precise mechanisms by which statins affect tendon integrity.
  • This case highlights a potential adverse drug reaction associated with combination statin-ezetimibe therapy.